स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - vildagliptinum - compresse - vildagliptinum 50.0 mg, cellulosum microcristallinum, lactosum 47.82 mg, carboxymethylamylum natricum a corresp. natrium max. 0.3 mg, magnesii stearas, pro compresso. - farmaco antidiabetico orale - synthetika

इटली - इतालवी - AIFA (Agenzia Italiana del Farmaco)

teva b.v. - metformina e vildagliptin - metformina e vildagliptin

इटली - इतालवी - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - metformina e vildagliptin - metformina e vildagliptin

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - vildagliptinum - compresse - vildagliptinum 50.000 mg, lactosum monohydricum 47.82 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 0.168 mg, magnesii stearas, pro compresso. - farmaco antidiabetico orale - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

nobel pharma schweiz ag - vildagliptinum - compresse - vildagliptinum 50 mg, lactosum 10 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 0.112 - 0.168 mg, magnesii stearas, pro compresso obducto. - il diabete mellito di tipo 2 - synthetika

यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - farmaci usati nel diabete - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - vildagliptinum, metformini hydrochloridum - compresse rivestite con film - vildagliptinum 50 mg metformini hydrochloridum 500 mg, hydroxypropylcellulosum, magnesio stearas, Überzug: hypromellosum, e 171, macrogolum 4000, talco, e 172 (giallo) e 172 (rosso), per compresso haze. - farmaco antidiabetico orale - synthetika